AnnouncementsPiramal Enterprises acquires brand CALADRYL in India
|Company Name||Last Price||%
|Dr Reddys Labs||2421.95||0.36||2545.00||1764.00||41,197.31|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
Piramal Enter is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 9,190.71 crore.The company has reported a consolidated sales of Rs 1138.89 crore and a Net Loss of Rs 30.79 crore for the quarter ended Sep 2013.
The company management includes Ajay G Piramal - Chairman, Swati A Piramal - Vice Chairman, Nandini Piramal - Executive Director, Vijay Shah - COO & Executive Director, Gautam Banerjee - Non Executive Director, Amit Chandra - Director, Keki Dadiseth - Director, R A Mashelkar - Director, Goverdhan Mehta - Director, Siddharth Mehta - Ind.& Non Exe.Director, S Ramadorai - Director, Deepak Satwalekar - Director, N Vaghul - Director.
It is listed on the BSE with a BSE Code of 500302 and the NSE with an NSE Code of PEL.
Its Registered office is at Piramal Tower, Ganpatrao Kadam Marg,,Lower Parel Mumbai,Maharashtra - 400013.
Their Registrars are Link Intime India Pvt. Ltd.